Amphetamine
Adzenys XR-ODT, Amphetamine Sulfate, DYANAVEL XR, Evekeo
Central Nervous System Stimulant
NADAC/unit
$0.3496
Active Shortage
Tier 1: 12.8%
PA Req: 2.4%
12 Manufacturers
28 ANDAs
Amphetamine treats ADHD and narcolepsy by increasing dopamine and norepinephrine activity.
vs. brand Adzenys XR-ODT: Generic saves up to 97% per unit
Active Shortages
2022-10-12 Shortage reported, Alvogen
2022-10-12 Shortage reported, Alvogen
2022-10-12 Shortage reported, Alvogen
2022-10-12 Estimated availability: 3/31/2026, Alvogen
2022-10-12 Supporting only contracted volume, Alvogen
Generic Manufacturers
ACTAVIS LABORATORIES FL INCALKEM LABORATORIES LTDAMNEAL PHARMACEUTICALS OF NEW YORK LLCAUROLIFE PHARMA LLCAZURITY PHARMACEUTICALS INCBIONPHARMA INCEPIC PHARMA LLCGRANULES PHARMACEUTICALS INCNEOS THERAPEUTICSPRINSTON PHARMACEUTICAL INCSANALUZ LLCSENORES PHARMACEUTICALS INCSPECGX LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.